A functional Jak2 tyrosine kinase domain is essential for mouse development. (Q52010851)

19 April 2018

title

A functional Jak2 tyrosine kinase domain is essential for mouse development. (English)

1 reference

19 April 2018

author

Kenneth Bernstein

6

1 reference

19 April 2018

author name string

Kristen Frenzel

1

1 reference

19 April 2018

Tiffany A Wallace

2

1 reference

19 April 2018

Issam McDoom

3

1 reference

19 April 2018

Hong D Xiao

4

1 reference

19 April 2018

Mario R Capecchi

5

1 reference

19 April 2018

Peter P Sayeski

7

1 reference

19 April 2018

language of work or name

English

0 references

publication date

16 May 2006

1 reference

19 April 2018

Experimental Cell Research

published in

1 reference

19 April 2018

volume

312

1 reference

19 April 2018

issue

15

1 reference

19 April 2018

page(s)

2735-2744

1 reference

19 April 2018

Janus kinases: components of multiple signaling pathways

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Jak2 is essential for signaling through a variety of cytokine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Distinct tyrosine phosphorylation sites in JAK3 kinase domain positively and negatively regulate its enzymatic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Tyrosine phosphorylation of Jak2 in the JH2 domain inhibits cytokine signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Regulation of the Jak2 tyrosine kinase by its pseudokinase domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

A region encompassing the FERM domain of Jak1 is necessary for binding to the cytokine receptor gp130

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

The Angiotensin II–Dependent Association of Jak2 and c-Src Requires the N-Terminus of Jak2 and the SH2 Domain of c-Src

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Janus kinase 2 determinants for growth hormone receptor association, surface assembly, and signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Tumor suppressor function of Bruton tyrosine kinase is independent of its catalytic activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in Pre-B cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Impaired precursor B cell differentiation in Bruton's tyrosine kinase-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

The erythropoietin receptor: dimerization, activation, and tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

The erythropoietin receptor: biogenesis, dimerization, and intracellular signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Growth hormone signalling and its regulation: preventing too much of a good thing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Crystal structure of the Src family tyrosine kinase Hck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Crystal structures of the human p56lck SH2 domain in complex with two short phosphotyrosyl peptides at 1.0 A and 1.8 A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Crystal structure of the tyrosine kinase domain of the human insulin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Protein structure prediction and structural genomics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Structure and stability of mRNA synthesized by vaccinia virus-encoded bacteriophage T7 RNA polymerase in mammalian cells. Importance of the 5' untranslated leader

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Targeting genes for self-excision in the germ line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Isolation of vascular smooth muscle cells from a single murine aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

Mutation of glutamic acid residue 1046 abolishes Jak2 tyrosine kinase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.004

10.1016/J.YEXCR.2006.05.004

7 January 2021

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018